Johnson's company, Johnson & Johnson, intends to petition for a license in the United States

A photo of a discarded face mask, provided by the dts News Agency, has been circulating on various platforms. The image does not specify the location where it was taken, nor does it indicate the condition or context in which the face mask was discarded. It's important to note that the photo does not contain any advertisements and does not provide any information about the person who discarded the mask.

Meanwhile, the U.S. pharmaceutical company Johnson & Johnson has applied for approval of its COVID-19 vaccine in the United States. The application was submitted through its subsidiary Janssen Biotech, following successful trials and authorizations in the EU, Canada, and Bahrain.

Johnson & Johnson's vaccine stands out due to its unique feature: it only requires one shot. This contrasts with the vaccines already approved in the EU, which typically require two doses. The vaccine has shown promising efficacy rates in clinical trials. In a global Phase 3 study, it was found to have an efficacy rate of 66 percent. If prevention of severe COVID-19 illness and deaths are also considered, the efficacy rate increases to 85 percent.

One significant development is the vaccine's effectiveness against the variant first discovered in South Africa. This is a crucial factor as new variants continue to emerge and pose challenges to existing vaccines.

The EU has already concluded a contract for the delivery of Johnson & Johnson's vaccine. The authorization request in the EU was announced after the company had already received authorization in the USA, Canada, and Bahrain. The EU’s Committee for Human Medicinal Products (CHMP) recommended conditional authorization on March 11, 2021. However, the specific entity that applied for authorization in the USA and the application announcement date are not yet publicly disclosed.

In the fight against the ongoing pandemic, the development and approval of new vaccines are crucial. As we await the U.S. approval of Johnson & Johnson's vaccine, it's essential to continue following public health guidelines, including wearing masks and maintaining social distancing, until then.

Johnson's company, Johnson & Johnson, intends to petition for a license in the United States